NCT00219310View on ClinicalTrials.gov

RELIEF: Randomized Episodic Versus Long-Term Suppression Experience With Famciclovir

PHASE4CompletedINTERVENTIONAL
Timeline

Start Date

June 30, 2003

Primary Completion Date

June 30, 2005

Study Completion Date

June 30, 2005

Conditions
Recurrent Genital Herpes (RGH)
Interventions
DRUG

Famciclovir

Trial Locations (1)

Unknown

Novartis Pharmaceuticals, East Hanover

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY